CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 96 enrolled
Drug / intervention
12 mL paracervical block +1 moredrug
Likely dose
12 mL paracervical blockfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03356145
NCT03356145Phase 4Completed
CompareCT.gov

12 Versus 20 mL Paracervical Block for Pain-Control During Cervical Preparation for Dilation and Evacuation: A Single-Blinded Randomized Controlled Trial

Stanford University·interventional·Posted Nov 29, 2017·Updated Jan 23, 2024

In Brief

A Phase 4 clinical trial evaluating 12 mL paracervical block and 20 mL paracervical block for Pain. Completed, enrolled 96 participants across 1 site.

Detailed Summary

More research is needed to investigate methods of pain control for cervical preparation for abortion procedures. Women report pain with paracervical block injection as well as with osmotic dilator placement. This study seeks to compare a 12 mL, 2-site 1% plain lidocaine paracervical block for pain control during cervical preparation (osmotic dilator insertion) for Dilation and Evacuation (D\&E) to a 20 mL 1% lidocaine 2-site paracervical block.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2017201820192020202120222023202420252026
First PostedNov 29, 2017
Enrollment StartJan 1, 2017
Primary CompletionOct 15, 2020
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 8.6 years ago

Interventions

12 mL paracervical blockdrug

Injection of 12 mL of lidocaine

20 mL paracervical blockdrug

Injection of 20 mL of lidocaine